Symbols

BBLG

Bone Biologics·NASDAQ

--(--)

7.05 / 10

Outperform

Analyst coverage is absent. Fund‑flow score is 7.05/10, labeled good, yet inflow ratios are modest and trends negative across all size segments, indicating cautious buying pressure.

Fund Flow Rating

Is money flowing into or out of BBLG?

BBLG holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.05/10 (Outperform).